The effect of SARS-CoV-2 vaccination on post-acute COVID-19 syndrome (PASC): A prospective cohort study 8 255 REFERENCES 1. Wynberg E, van Willigen HDG, Dijkstra M, et al. Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset. Clinical Infectious Diseases 2021. 2. Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Global Health 2021; 6(9): e005427. 3. WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization (WHO) clinical case definition working group on post COVID-19 condition 2021. 4. Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series. Ann Intern Med 2021; 174(9): 1334-6. 5. Tran V-TP, Elodie; Saldanha, Julia; Pane, Isabelle; Ravaud, Philippe. Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data From the ComPaRe e-Cohort in France. SSRN Pre-Print 2021. 6. Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nature Communications 2022; 13(1): 446. 7. ISARIC. Clinical Data Collection – The COVID-19 Case Report Forms (CRFs). Available at: https:// isaric.org/research/covid-19-clinical-research-resources/covid-19-crf/. Accessed 18 Feb. 8. Rijksoverheid. Aanpak coronavaccinatie in Nederland. Available at: https://www.rijksoverheid. nl/onderwerpen/coronavirus-vaccinatie/aanpak-coronavaccinatie. Accessed 10 Nov. 9. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine 2020; 383(27): 2603-15. 10. World Health Organization. COVID-19 Clinical management: living guidance, 2021 25 January 2021. 11. Brouwer PA-O, Caniels TA-OX, van der Straten KA-O, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. (1095-9203 (Electronic)). 12. van Gils MJ, van Willigen HDG, Wynberg E, et al. A Single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern. Cell Reports Medicine. 13. Brouwer PJM, Brinkkemper M, Maisonnasse P, et al. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell 2021; 184(5): 1188-200.e19. 14. Schmidt F, Weisblum Y, Muecksch F, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. LID - 10.1084/jem.20201181 [doi] LID - e20201181. (1540-9538 (Electronic)). 15. Iacus SM, King G, Porro G. Causal Inference without Balance Checking: Coarsened Exact Matching. Political Analysis 2012; 20(1): 1-24. 16. Salvatier JW, TV.; Fonnesbeck, C. Probabilistic programming in Python using PyMC3. PeerJ Computer Science 2016; 2. 17. Ayoubkhani D, Bermingham C, Pouwels KB, et al. Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study. medRxiv 2021: 2021.12.09.21267516. 18. Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. medRxiv 2021: 2021.10.26.21265508.
RkJQdWJsaXNoZXIy MTk4NDMw